# Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer

> **NCT02672098** · PHASE1 · COMPLETED · sponsor: **Loma Linda University** · enrollment: 3 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **PROCEDURE:** Hyperthermic intraperitoneal chemotherapy (HIPEC)
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT02672098
- **Lead sponsor:** Loma Linda University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-14
- **Primary completion:** 2023-04-19
- **Final completion:** 2023-04-19
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2025-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02672098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02672098, "Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02672098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*